Growth Metrics

Mannkind (MNKD) Cash & Equivalents (2010 - 2026)

Mannkind (MNKD) reported Cash & Equivalents of $53.6 million for Q1 2026, up 11.51% year-over-year from $48.1 million in Q1 2025, and down 28.45% on a QoQ basis from $74.9 million in Q4 2025.

Mannkind (MNKD) has 17 years of Cash & Equivalents data on file, last reported at $53.6 million in Q1 2026.

  • Quarterly Cash & Equivalents rose 11.51% year-over-year to $53.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $53.6 million (up 11.51% YoY) and the FY2025 annual result came in at $74.9 million, up 59.07% from the prior year.
  • Cash & Equivalents retreated to $53.6 million in Q1 2026 per MNKD's latest filing, from $74.9 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $238.5 million in Q4 2023 and bottomed at $35.5 million in Q2 2022.
  • The 5-year median for Cash & Equivalents is $69.8 million (2022), against an average of $87.2 million.
  • The widest annual swing landed in 2023, when Cash & Equivalents surged 241.82%; it then tumbled 80.26% in 2024.
  • Tracing MNKD's Cash & Equivalents over 5 years: stood at $69.8 million in 2022, then surged by 241.82% to $238.5 million in 2023, then plunged by 80.26% to $47.1 million in 2024, then soared by 59.07% to $74.9 million in 2025, then retreated by 28.45% to $53.6 million in 2026.
  • Per Business Quant, the three latest MNKD Cash & Equivalents figures stand at $53.6 million (Q1 2026), $74.9 million (Q4 2025), and $127.4 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 1.91 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 32.30 Mn
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 286.70 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 61.46 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 2.77 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 5.49 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - 18.44 Mn
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 2.96 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1.71 Bn
10 Mannkind 1.09 Bn 956.66 Mn 82.66 Mn 53.58 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 53.58 Mn
Dec 31, 2025 74.88 Mn
Sep 30, 2025 127.39 Mn
Jun 30, 2025 57.01 Mn
Mar 31, 2025 48.05 Mn
Dec 31, 2024 47.08 Mn
Sep 30, 2024 63.11 Mn
Jun 30, 2024 97.38 Mn
Mar 31, 2024 193.27 Mn
Dec 31, 2023 238.48 Mn
Sep 30, 2023 83.02 Mn
Jun 30, 2023 86.18 Mn
Mar 31, 2023 85.87 Mn
Dec 31, 2022 69.77 Mn
Sep 30, 2022 54.31 Mn
Jun 30, 2022 35.50 Mn
Mar 31, 2022 67.20 Mn
Dec 31, 2021 124.18 Mn
Sep 30, 2021 51.70 Mn
Jun 30, 2021 62.50 Mn
Mar 31, 2021 247.83 Mn
Dec 31, 2020 67.01 Mn
Sep 30, 2020 52.40 Mn
Jun 30, 2020 63.22 Mn
Mar 31, 2020 38.87 Mn
Dec 31, 2019 29.91 Mn
Sep 30, 2019 30.17 Mn
Jun 30, 2019 7.97 Mn
Mar 31, 2019 34.53 Mn
Dec 31, 2018 71.16 Mn
Sep 30, 2018 10.45 Mn
Jun 30, 2018 26.18 Mn
Mar 31, 2018 26.71 Mn
Dec 31, 2017 43.95 Mn
Sep 30, 2017 10.00 Mn
Jun 30, 2017 43.38 Mn
Mar 31, 2017 47.98 Mn
Dec 31, 2016 22.90 Mn
Sep 30, 2016 35.53 Mn
Jun 30, 2016 63.73 Mn
Mar 31, 2016 27.65 Mn
Dec 31, 2015 59.07 Mn
Sep 30, 2015 32.93 Mn
Jun 30, 2015 107.19 Mn
Mar 31, 2015 120.84 Mn
Dec 31, 2014 120.84 Mn
Sep 30, 2014 172.47 Mn
Jun 30, 2014 41.21 Mn
Mar 31, 2014 35.76 Mn
Dec 31, 2013 70.79 Mn
Sep 30, 2013 93.80 Mn
Jun 30, 2013 28.53 Mn
Mar 31, 2013 28.01 Mn
Dec 31, 2012 61.84 Mn
Sep 30, 2012 1.77 Mn
Jun 30, 2012 31.64 Mn
Mar 31, 2012 56.36 Mn
Dec 31, 2011 2.68 Mn
Sep 30, 2011 22.79 Mn
Jun 30, 2011 24.77 Mn
Mar 31, 2011 46.91 Mn
Dec 31, 2010 66.06 Mn
Sep 30, 2010 97.93 Mn
Jun 30, 2010 28.36 Mn